Back
Aptevo Therapeutics Vs. Repligen Industry Stock Comparison
Sell
31
APVO
Aptevo Therapeutics
Last Price:
0.21
Seasonality Move:
-25.41%
Sell
30
RGEN
Repligen
Last Price:
124.90
Seasonality Move:
7.3%
Sell
31
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy, Sell or Hold?
- The current Aptevo Therapeutics [APVO] share price is $0.21. The Score for APVO is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- APVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Repligen (RGEN)
is a Sell
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APVO Stock Price Chart
What is Aptevo Therapeutics's stock price today?
-
The Aptevo Therapeutics share price today is $0.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing selling pressure, which indicates risk of future bearish movement.
APVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 43.7 | Sell |
| Chaikin Money Flow: | -700208 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.2 - 0.3) | Sell |
| Bollinger Bands (100): | (0.21 - 0.41) | Sell |
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.46 | Sell |
| Relative Strength Index (14 RSI): | 36.22 | Sell |
| Chaikin Money Flow: | -1285419 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (134.94 - 146.38) | Sell |
| Bollinger Bands (100): | (130 - 153.64) | Sell |
APVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.26 | Sell |
| 20-day SMA: | 0.27 | Sell |
| 50-day SMA: | 0.23 | Sell |
| 200-day SMA: | 1.64 | Sell |
| 8-day EMA: | 0.25 | Sell |
| 20-day EMA: | 0.25 | Sell |
| 50-day EMA: | 0.27 | Sell |
| 200-day EMA: | 5.75 | Sell |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 142.02 | Sell |
| 20-day SMA: | 140.23 | Sell |
| 50-day SMA: | 141.19 | Sell |
| 200-day SMA: | 157.58 | Sell |
| 8-day EMA: | 139.7 | Sell |
| 20-day EMA: | 140.54 | Sell |
| 50-day EMA: | 141.71 | Sell |
| 200-day EMA: | 151.3 | Sell |
Aptevo Therapeutics Earnings Growth & APVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $95.13 per share, and an increase next year of $1.74 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.
Aptevo Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Repligen Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||